NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

That axis appears to show different patient activated vs replacement DCs. Certain DCs may be able to not only deliver higher cytokine levels but may be able to remain longer in the tumor microenvironment before being genetically modified by it to become circulatory. This would be a key factor to maintaining an increasingly effective immune response to the point of tumor defense degradation. The point of no return so to speak where the tumor defenses become overwhelmed.